Penicillamine in interstitial lung disease: A timely remainder of an old foe

S. Pawadshettar, V. K. Acharya, M. Arun, B. Unnikrishnan, B. V. Tantry

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Penicillamine-induced lung injury has been sparsely reported in the literature. We report one such case with its wide-ranging ramifications. We present an unusual case of drug induced-interstitial lung disease (DI-ILD) caused by penicillamine, resulting in acute lung injury in a young patient with Wilson’s liver disease. Patient had a interstial lung disease which was attributed to the drug pencillamine. Penicillamine-induced lung injury has been sparsely reported in the literature and dose-dependent toxicity in a patient with neuro-psychiatric diseases adds to the rarity of the case. Furthermore, the complexities involved in diagnosing DI-ILD are deliberated.

Original languageEnglish
Pages (from-to)351-353
Number of pages3
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume9
Issue number1
Publication statusPublished - 01-01-2016

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology
  • Pharmacology (medical)

Cite this